January 2, 2008 - Echo Therapeutics Inc. said today it started a second clinical study of its current Symphony Continuous Transdermal Glucose Monitoring System (CTGM System) at the Tufts-New England Medical Center (Tufts-NEMC) and expects to announce the results in the first quarter of 2008.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now